• Explore /
  • Poster
  • / Real-world outcomes in first-line treatment of metastatic castration-resistant prostate cancer (mCRPC): The prostate cancer registry.

Real-world outcomes in first-line treatment of metastatic castration-resistant prostate cancer (mCRPC): The prostate cancer registry.

Abstract Poster

Authors

null

Simon Chowdhury

Guy's, King's and St. Thomas' Hospitals, London, United Kingdom

Simon Chowdhury , Alison J. Birtle , Anders Bjartell , Luis Costa , Susan Feyerabend , Luca Galli , Ewa Kalinka-Warzocha , Gero Kramer , Nicolaas Lumen , Pablo Maroto , Vsevolod B. Matveev , Thomas Paiss , Salvatore Pisconti , Dominique Spaeth , Laurent Antoni , Edwin Klumper , Robert Wapenaar , Erik Van Den Berg , Emma Lee

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

NCT02236637

Citation

J Clin Oncol 35, 2017 (suppl 6S; abstract 212)

DOI

10.1200/JCO.2017.35.6_suppl.212

Abstract #

212

Poster Bd #

H14

Abstract Disclosures

Similar Posters

First Author: Arpit Rao

First Author: Arpit Rao

First Author: Yushi Naito

First Author: Emily Nash Smyth